Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
    Cochrane Systematic Reviews, 4-Jan-2015
  • Antibiotics for community‐acquired pneumonia in adult outpatients
    Cochrane Systematic Reviews, 9-Oct-2014
  • Antibiotics for community‐acquired pneumonia in children
    Cochrane Systematic Reviews, 4-Jun-2013
  • Antibiotics for exacerbations of asthma
    Cochrane Systematic Reviews, 25-Jun-2018
  • Antibiotics for exacerbations of chronic obstructive pulmonary disease
    Cochrane Systematic Reviews, 29-Oct-2018
  • Antibiotics for persistent nasal discharge (rhinosinusitis) in children
    Cochrane Systematic Reviews, 12-Dec-2007
  • Antibiotics for preterm rupture of membranes
    Cochrane Systematic Reviews, 2-Dec-2013
  • Antibiotics for prolonged wet cough in children
    Cochrane Systematic Reviews, 31-Jul-2018
  • Antibiotics for the common cold and acute purulent rhinitis
    Cochrane Systematic Reviews, 4-Jun-2013
  • Antibiotics for treating community‐acquired pneumonia in people with sickle cell disease
    Cochrane Systematic Reviews, 14-Nov-2016
  • Antibiotics for treatment of sore throat in children and adults
    Cochrane Systematic Reviews, 9-Dec-2021
  • Antibiotics for ureaplasma in the vagina in pregnancy
    Cochrane Systematic Reviews, 7-Sep-2011
  • Antibiotics for whooping cough (pertussis)
    Cochrane Systematic Reviews, 10-Feb-2013
  • Antibiotics to reduce post‐tonsillectomy morbidity
    Cochrane Systematic Reviews, 12-Dec-2012
  • Anticholinergic agents for chronic asthma in adults
    Cochrane Systematic Reviews, 19-Jul-2004
  • Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
    Cochrane Systematic Reviews, 20-Jan-2003
  • Anticholinergic drugs for wheeze in children under the age of two years
    Cochrane Systematic Reviews, 20-Jul-2005
  • Anticholinergic therapy for acute asthma in children
    Cochrane Systematic Reviews, 29-Feb-2012
  • Anticholinergic therapy for bronchiectasis
    Cochrane Systematic Reviews, 23-Apr-2001
  • Anticholinergic therapy for chronic asthma in children over two years of age
    Cochrane Systematic Reviews, 21-Jul-2003
[x]

Login or Subscribe

Login

Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More